☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

OTC Deregulation

The Medicines and Healthcare products Regulatory Agency has announced the deregulation of Amorolfine and Sumatriptan.

Amorolfine is a nail lacquer licensed for the treatment of mild fungal infections of the nails. The over the counter product is called Curanail®. The Pharmaceutical Journal reports and can only be sold to patients over 18 years old with distal or lateral infection affecting up to two nails. The recommended price is £18.61.

Sumatriptan is a tablet licensed for the relief of acute migraine attacks. The over the counter product is called Imigran Recovery®. The BBC report that this product is likely to be available from mid-June at a cost of £7.99 for 2 tablets.

Action: The newly deregulated status of these products is likely to raise public interest and possibly result in increased GP consultations, especially in light of the recommended prices.

Share 'OTC Deregulation' by emailShare 'OTC Deregulation' on FacebookShare 'OTC Deregulation' on TwitterShare 'OTC Deregulation' on LinkedInShare 'OTC Deregulation' on reddit


No Comments to “OTC Deregulation”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.